BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31755936)

  • 1. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.
    Makinson A; Dubois J; Eymard-Duvernay S; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; Gény C; Thouvenot E; Costagliola D; Ozguler A; Zins M; Simony M; Reynes J; Berr C
    Clin Infect Dis; 2020 Jun; 70(12):2641-2648. PubMed ID: 31755936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled Study.
    Lellouche L; Gutierrez LA; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; Ozguler A; Zins M; Nailler L; Reynes J; Berr C; Makinson A
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):305-309. PubMed ID: 34238822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
    Moulignier A; Savatovsky J; Assoumou L; Lescure FX; Lamirel C; Godin O; Valin N; Tubiana R; Canestri A; Roux P; Sadik JC; Salomon L; Abrivard M; Katlama C; Yazdanpanah Y; Pialoux G; Girard PM; Costagliola D;
    Clin Infect Dis; 2018 May; 66(11):1762-1769. PubMed ID: 29244126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.
    Hiransuthikul A; Chutinet A; Sakulrak S; Samajarn J; Vongsayan P; Kijpaisalratana N; Akarathanawat W; Apornpong T; Sangarlangkarn A; Gatechompol S; Han WM; Chattranukulchai P; Kerr S; Ruxrungtham K; Avihingsanon A
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1170-1173. PubMed ID: 31588776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review.
    Aung HL; Aghvinian M; Gouse H; Robbins RN; Brew BJ; Mao L; Cysique LA
    AIDS Behav; 2021 Mar; 25(3):917-960. PubMed ID: 33025390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
    Métral M; Darling K; Locatelli I; Nadin I; Santos G; Brugger P; Kovari H; Cusini A; Gutbrod K; Tarr PE; Calmy A; Lecompte TD; Assal F; Monsch A; Kunze U; Stoeckle M; Schwind M; Schmid P; Pignatti R; Di Benedetto C; Du Pasquier R; Cavassini M; ;
    HIV Med; 2020 Jan; 21(1):30-42. PubMed ID: 31589807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus-Specific CD4+ T-cell Responses and CMV-IgG Levels Are Associated With Neurocognitive Impairment in People Living With HIV.
    Ballegaard V; Pedersen KK; Pedersen M; Brændstrup P; Kirkby N; Buus AS; Ryder LP; Gerstoft J; Nielsen SD
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):117-125. PubMed ID: 29781883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort.
    Bonnet F; Le Marec F; Leleux O; Gerard Y; Neau D; Lazaro E; Duffau P; Caubet O; Vandenhende MA; Mercie P; Cazanave C; Dabis F
    BMC Infect Dis; 2020 Nov; 20(1):850. PubMed ID: 33198667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of HIV exposure and excess burden of neurocognitive impairment in people living with HIV: a protocol for systematic review and meta-analysis of controlled studies.
    Ayu AP; Rahadi A; Kristian K; Sani TP; Putra A; Halim G; Mangkuliguna G; Kusumoputri TP; Turana Y
    Syst Rev; 2023 Nov; 12(1):214. PubMed ID: 37968747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Veterans Aging Cohort Study (VACS) index and neurocognitive function among people living with HIV-a cross sectional study in coastal South India.
    Ganapathy A; Achappa B; Kulkarni V; Madi D; Holla R; Bhaskaran U; Rathi P; Mahalingam S; Dsouza NV
    AIDS Res Ther; 2021 Aug; 18(1):47. PubMed ID: 34348754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
    Watson CW; Paolillo EW; Morgan EE; Umlauf A; Sundermann EE; Ellis RJ; Letendre S; Marcotte TD; Heaton RK; Grant I
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):56-64. PubMed ID: 31809361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
    Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
    J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with severe depressive symptoms in older west African people living with HIV.
    Bernard C; Font H; Diallo Z; Ahonon R; Tine JM; N'guessan Abouo F; Tanon A; Messou E; Seydi M; Dabis F; de Rekeneire N;
    BMC Psychiatry; 2020 Sep; 20(1):442. PubMed ID: 32912173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurocognitive impairment and characteristics of neurocognitive performance among people with HIV on antiretroviral treatment].
    Xia JJ; Wang SL; Hu YF; Shen WW; Lin HJ; Shi RZ; Ma ZH; Li ZH; Li SZ; Ding YY; Chen XX; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1651-1657. PubMed ID: 36456499
    [No Abstract]   [Full Text] [Related]  

  • 20. Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus.
    Erlandson KM; Perez J; Abdo M; Robertson K; Ellis RJ; Koletar SL; Kalayjian R; Taiwo B; Palella FJ; Tassiopoulos K
    Clin Infect Dis; 2019 Jan; 68(1):131-138. PubMed ID: 29788039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.